Demographic and haematological characteristics at enrolment in G6PD normal children.

NIAID Data Ecosystem2026-03-06 收录

数据链接：

https://figshare.com/articles/dataset/_Demographic_and_haematological_characteristics_at_enrolment_in_G6PD_normal_children_/599740 数据链接链接失效反馈

官方服务：

资源简介：

AS = artesunate; AQ = amodiaquine; AL = artemether-lumefantrine; CD = chlorproguanil-dapsone

创建时间：

2008-06-25

PCR-corrected parasitological cure at Day 28 (primary endpoint), Day 14 and Day 42 (secondary endpoints).

疟疾药物临床试验

PCR校正疗效评估

*In the PP analysis, patients with missing data were excluded and patients with new infections (determined by PCR) were considered successes at the first time point that this outcome was recorded, but

NIAID Data Ecosystem40

Patients enrolled in antimalarial drug efficacy trials who received MAS3, between 1995 and 2007, on the northwestern border of Thailand.

疟疾药物临床试验

流行病学监测

Patients enrolled in antimalarial drug efficacy trials who received MAS3, between 1995 and 2007, on the northwestern border of Thailand.

Figshare2015-12-02 更新10

Baseline characteristics of patients with uncomplicated P. falciparum malaria enrolled in the Phase I/II study of sevuparin (TSM02)*.

疟疾药物临床试验

患者基线特征

Baseline characteristics of patients with uncomplicated P. falciparum malaria enrolled in the Phase I/II study of sevuparin (TSM02)*.

Figshare2017-12-16 更新10

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

疟疾药物临床试验

耐药性监测

BackgroundThe predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted us

NIAID Data Ecosystem20

Dataset from Study 200894: A Double-blind, Double-dummy, Randomized, Parallel Group, Placebo-controlled Superiority Study to Evaluate the Efficacy and Safety of Tafenoquine (SB-252263, WR238605) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax Malaria

疟疾药物临床试验

间日疟根治疗法

Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in development as a single-dose treatment for the radical cure of P.vivax malaria when given with standard doses of chloroquine. C

NIAID Data Ecosystem10

Demographic and haematological characteristics at enrolment in G6PD normal children.

资源简介：

相关数据集